Proof in Recovery

Digital therapeutics and remote patient monitoring for substance use disorders
Overview
Raised: $59,426
Rolling Commitments ($USD)
05/31/2022
$512
34
2018
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Medium
Low
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$49,000 |
$0 |
COGS |
$24,500 |
$0 |
Tax |
$450 |
$0 |
| ||
| ||
Net Income |
$-39,875 |
$-2,242 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$2,395 |
$427 |
Accounts Receivable |
$49,000 |
$0 |
Total Assets |
$51,395 |
$427 |
Short-Term Debt |
$24,500 |
$0 |
Long-Term Debt |
$40,000 |
$25,000 |
Total Liabilities |
$64,500 |
$25,000 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual